MigVax is developing an oral subunit vaccine for COVID-19.
Humanity has never faced such a challenge - develop a vaccine within 18 months!
MigVax team has combined decades of track record with successful global vaccine and
pharmaceutical achievements.
- Requirements Proficiency in Protein Biochemistry(hands on):
o Protein expression in E coli, yeast, insect and/or mammalian cells
o Protein purification – SEC, Inversed Phase, affinity (Akta)
o Manufacturing process development
o Protein analysis: ELISA, WB, impurities (HPLC)
o Protein activity analysis: Cell-based assays development and performance, binding
assays
o Experience in assay qualification and validation is a great advantage
o Knowledge of GMP-based documentation in an R&D environment
- Experience in writing of quality documents: SOPs, protocols, research reports
- Experience in the writing of the scientific part of CMC (under RA support) – big advantage
- Team management experience is an advantage.
- Subcontractors daily management and guidance/collaboration experience is an advantage.
